News
13 July 2010
Top Institute Pharma reaction to the closure of the MSD R&D facility in Oss, the Netherlands.
TI Pharma has taken note of the news of the closure of the MSD R&D facility in Oss, the Netherlands. The research conducted by our partners is of great value for the knowledge infrastructure in the Dutch life sciences and health sector.
Top Institute Pharma will continue to focus on managing public-private consortia in which scientific and business worlds work together on groundbreaking, multidisciplinary research aimed at improving the development of socially valuable medicines. Together with her 45 (international) pharmaceutical and biotechnology partners as well as our 28 academic partners, Top Institute Pharma will continue to address the challenges and opportunities faced by pharmaceutical research in the Netherlands.
